Arrowpoint Investment Partners (Singapore) Pte. Ltd.
Position in A — Agilent Technologies, Inc.
CIK 2032331
SINGAPORE, U0
Position in A
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$2,899,147
+$2,157,028 QoQ
Shares Held
21,826
+277.5% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.89%
of 13F equity value
Holder Rank
#350
of 1,112 holders
Holding Since
Dec 2024
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in A Over Time
Shares Held
Position Value (USD)
Derivatives in A
reported options exposure · as of Dec 31, 2024CallValue
$886,644
CallShares
6,600
PutValue
$779,172
PutShares
5,800
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Arrowpoint Investment Partners (Singapore) Pte. Ltd. holds $9,205,676 across 6 Diagnostics & Research names. A ranks #2 (31.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVTY |
Revvity, Inc.
|
27,316 | $3,039,178 | |
| 2 | A |
Agilent Technologies, Inc.
This page
|
21,826 | $2,899,147 | |
| 3 | TWST |
Twist Bioscience Corp
|
20,287 | $2,087,126 | |
| 4 | NTRA |
Natera, Inc.
|
2,814 | $763,860 | |
| 5 | ILMN |
Illumina, Inc.
|
2,368 | $416,365 | |
| 6 | ADPT |
Adaptive Biotechnologies Corp
|
3,787 | $0 |
All Filings in A
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,899,147 | 21,826 | Shares | Defined | 2026-08-13 | |
| 2025-09-30 | $742,119 | 5,782 | Shares | Defined | 2025-11-14 | |
| 2024-12-31 | $495,714 | 3,690 | Shares | Defined | 2025-02-18 | |
| 2024-12-31 | $886,644 | 6,600 | Call | Defined | 2025-02-18 | |
| 2024-12-31 | $779,172 | 5,800 | Put | Defined | 2025-02-18 | |
| No filing history on record for this holder in this stock. | ||||||